Description
Thrombin receptor agonist is a peptide that activates thrombin-mediated platelet aggregation signaling pathways; it mimics the effects of thrombin, activating protease-activated receptor-1 (PAR1) in wounds in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Thrombin receptor agonist is a peptide that activates thrombin-mediated platelet aggregation signaling pathways; it mimics the effects of thrombin, activating protease-activated receptor-1 (PAR1) in wounds in vivo.
| Cas No. | 137339-65-2 |
|---|---|
| Purity | ≥95% |
| Formula | C81H118N20O23 |
| Formula Wt. | 1739.96 |
| Synonym | TRAP-14, TRAP |
| Solubility | Soluble in water (0.9 mg/mL). |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Windeløv NA, Sørensen AM, Perner A, et al. Platelet aggregation following trauma: a prospective study. Blood Coagul Fibrinolysis. 2014 Jan;25(1):67-73. PMID: 23945060.
Kreutz RP, Breall JA, Kreutz Y, et al. Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response. Thromb Res. 2012 Aug;130(2):198-202. PMID: 22459907.
GABA potentiator, voltage-gated Na+ and ATP-sen...
Indoleamine 2,3-dioxygenase inhibitor.
Potential AhR binding agent.
GSK-3β, HGK, and CDK inhibitor.
HDAC6 inhibitor.
Found in Salvia; MAG lipase inhibitor.
Polyphenol derivative of caffeic acid found in ...
VEGFR2, c-Met, RET inhibitor.
Cysteine-ITC conjugate, antioxidant.
Inhibitor of PI3K.
Voltage-gated K+ channel blocker.
AKT inhibitor, potential ROCK, p70S6K, PKA, MKK...
Inhibitor of FAK and ALK.
Histamine H2 antagonist, GSK-3β inhibitor.
Caspase 3 substrate.
p110γ PI3K inhibitor.
Piperadine phenothiazine; FIASMA, D1-5, histami...
Amphiphilic properties
S-enantiomer of citalopram; SERT inhibitor.
Naturally produced ITC, sulfonyl analog of sulf...